#Heart Health Technology

[drsanjaykumar]

In recent years, advancements in cardiac technology have significantly transformed the treatment landscape for patients with heart rhythm disorders. One of the most notable innovations is the leadless pacemaker, a breakthrough that has redefined how cardiologists manage conditions like bradycardia. Dr. Sanjay Kumar, a prominent cardiologist and Director of Cardiology at Fortis Escorts Hospital in Faridabad, is at the forefront of this evolution in heart care, emphasizing the critical role of leadless pacemakers in improving patient outcomes and overall quality of life.

[jcmarchi]

New method enables fast, accurate estimates of cardiovascular state to inform blood pressure management

New Post has been published on https://thedigitalinsider.com/new-method-enables-fast-accurate-estimates-of-cardiovascular-state-to-inform-blood-pressure-management/

New method enables fast, accurate estimates of cardiovascular state to inform blood pressure management

If patients receiving intensive care or undergoing major surgery develop excessively high or low blood pressures, they could suffer severe organ dysfunction. It’s not enough for their care team to know that pressure is abnormal. To choose the correct drug to treat the problem, doctors must know why blood pressure has changed. A new MIT study presents the mathematical framework needed to derive that crucial information accurately and in real time.

The mathematical approach, described in a recent open-access study in IEEE Transactions on Biomedical Engineering, produces proportional estimates of the two critical factors underlying blood pressure changes: the heart’s rate of blood output (cardiac output) and the arterial system’s resistance to that blood flow (systemic vascular resistance). By applying the new method to previously collected data from animal models, the researchers show that their estimates, derived from minimally invasive measures of peripheral arterial blood pressure, accurately matched estimates using additional information from an invasive flow probe placed on the aorta. Moreover, the estimates accurately tracked the changes induced in the animals by the various drugs physicians use to correct aberrant blood pressure.

“Estimates of resistance and cardiac output from our approach provide information that can readily be used to guide hemodynamic management decisions in real time,” the study authors wrote.

With further testing leading to regulatory approval, the authors say, the method would be applicable during heart surgeries, liver transplants, intensive care unit treatment, and many other procedures affecting cardiovascular function or blood volume.

“Any patient who is having cardiac surgery could need this,” says study senior author Emery N. Brown, the Edward Hood Taplin Professor of Medical Engineering and Computational Neuroscience in The Picower Institute for Learning and Memory, the Institute for Medical Engineering and Science, and the Department of Brain and Cognitive Sciences at MIT. Brown is also an anesthesiologist at Massachusetts General Hospital and a professor of anesthesiology at Harvard Medical School. “So might any patient undergoing a more normal surgery but who might have a compromised cardiovascular system, such as ischemic heart disease. You can’t have the blood pressure being all over the place.”

The study’s lead author is electrical engineering and computer science (EECS) graduate student Taylor Baum, who is co-supervised by Brown and Munther Dahleh, the William A. Coolidge Professor in EECS.

Algorithmic advance

The idea that cardiac output and systemic resistance are the two key components of blood pressure comes from the two-element Windkessel model. The new study is not the first to use the model to estimate these components from blood pressure measurements, but previous attempts ran into a trade-off between quick estimate updates and the accuracy of estimates; methods would either provide more erroneous estimates at every beat or more reliable estimates that are updated at minute time scales. Led by Baum, the MIT team overcame the trade-off with a new approach of applying statistical and signal processing techniques such as “state-space” modeling.

“Our estimates, updated at every beat, are not just informed by the current beat; but they incorporate where things were in previous beats as well,” Baum says. “It’s that combination of past history and current observations that produces a more reliable estimate while still at a beat-by-beat time scale.”

Notably, the resulting estimates of cardiac output and systemic resistance are “proportional,” meaning that they are each inextricably linked in the math with another co-factor, rather than estimated on their own. But application of the new method to data collected in an older study from six animals showed that the proportional estimates from recordings using minimally invasive catheters provide comparable information for cardiovascular system management.

One key finding was that the proportional estimates made based on arterial blood pressure readings from catheters inserted in various locations away from the heart (e.g., the leg or the arm) mirrored estimates derived from more invasive catheters placed within the aorta. The significance of the finding is that a system using the new estimation method could in some cases rely on a minimally invasive catheter in various peripheral arteries, thereby avoiding the need for a riskier placement of a central artery catheter or a pulmonary artery catheter directly in the heart, the clinical gold standard for cardiovascular state estimation.

Another key finding was that when the animals received each of five drugs that doctors use to regulate either systemic vascular resistance or cardiac output, the proportional estimates tracked the resulting changes properly. The finding therefore suggests that the proportional estimates of each factor are accurately reflecting their physiological changes.

Toward the clinic

With these encouraging results, Baum and Brown say, the current method can be readily implemented in clinical settings to inform perioperative care teams about underlying causes of critical blood pressure changes. They are actively pursuing regulatory approval of use of this method in a clinical device.

Additionally, the researchers are pursuing more animal studies to validate an advanced blood pressure management approach that uses this method. They have developed a closed-loop system, informed by this estimation framework, to precisely regulate blood pressure in an animal model. Upon completion of the animal studies, they will apply for regulatory clearance to test the system in humans.

In addition to Baum, Dahleh and Brown, the paper’s other authors are Elie Adam, Christian Guay, Gabriel Schamberg, Mohammadreza Kazemi, and Thomas Heldt.

The National Science Foundation, the National Institutes of Health, a Mathworks Fellowship, The Picower Institute for Learning and Memory, and The JPB Foundation supported the study.

[cbirt]

Occlusion myocardial infarction (OMI) impacts a large number of people, yet fewer get diagnosed. This is because their ECG fails to show an elevation in the ST region. An elevated ST region indicates the presence of OMI. Such patients can receive great help from immediate reperfusion therapy, but the problem is that no tool can accurately identify them in the initial assessment. At the University of Pittsburgh, USA, scientists conducted a study with a sample space of 7,313 patients in the US with the aim of developing machine-learning models for detecting OMI effectively through ECG. The developed models showed higher accuracy, precision, and sensitivity, outperforming clinicians and commercial interpretation systems. The features of the models were validated by clinical experts as well, increasing the scope for a better understanding of the underlying mechanisms of OMI.

Effective ECG diagnosis of acute coronary syndrome (ACS) in individuals with acute chest pain has long been difficult. Blockages in the coronary arteries cause ACS, a condition where there is less blood flow to the heart. To segregate individuals with ST-elevation myocardial infarction (STEMI) from those with other kinds of ACS, clinicians analyze ST-segment elevation (STE). In the absence of STE on the ECG, a biomarker-driven approach is followed. 

The biomarker-driven approach involves the measurement of cardiac biomarkers such as troponin. But this approach has two significant limitations. First, 25 to 35 percent of individuals with non-STEMI experience occlusion myocardial infarction (OMI), which entails total coronary artery blockage. Such patients are more vulnerable than patients with ACS with an open artery and require urgent insertion of a catheter into the blood vessels of their heart. They are also subjected to unnecessary treatment delays, which obviously increase their mortality risk. Even though ECG findings capable of indicating OMI are described in the literature, they are subtle and include complex changes in the ECG waveform. Thus, visual interpretation by clinical experts proves to be a rather suboptimal approach.

Continue Reading

[heartnetindia]

How Telemedicine Enhances Emergency Cardiac Care

Telemedicine is revolutionizing solutions in healthcare and medical science. It is healthcare delivery especially helpful in emergency conditions. With the emergence of advanced healthcare services integration of telemedicine has become a true blessing for humankind. Also, telemedicine solutions play a crucial role in emergency cardiac care. 

In this blog, we are going to explore how telemedicine can enhance emergency cardiac care and make emergency cardiac treatment more accessible and effective. 

What is telemedicine? 

Telemedicine plays a crucial role in emergency care, including cardiac emergencies. However, before we talk about the impact of telemedicine for cardiac care, let's learn briefly about what is telemedicine at first briefly. Telemedicine is also known as telehealth, which uses electronic information and communication technologies to provide healthcare services and support remotely. Telemedicine also enhances both the efficiency and accuracy of emergency healthcare services.

Telemedicine in Emergency Cardiac Care 

Telemedicine solutions help in more than one way to enhance emergency cardiac condition support. Here, we will discuss some essential ways telemedicine helps to enhance emergency cardiac care-

Enhanced triage and consultation 

The first and foremost essential way telemedicine helps to enhance emergency cardiac care is by enhancing triage and consultation. Tele-triage helps healthcare providers to assess the condition of the patient and its severity remotely from a distance. This ensures that cardiac patients get accurate care and support, especially during emergencies. Such telehealth technologies also enable instant consultation from emergency physicians and cardiac specialists.

Enhanced access to emergency care

Another essential way telemedicine helps to improve emergency cardiac care is by enhancing access to emergency care. A cardiac emergency is a critical state that requires immediate access to emergency cardiac care to save a patient's life. And these telehealth solutions work excellently in providing emergency care in cardiac emergencies. Nowadays, cardiac patients can access emergency cardiac care services by leveraging these telehealth solutions, which makes emergency cardiac care more accessible during emergencies. 

Improved decision-making

Decision-making is an essential part of emergency cardiac care. Delays in decision-making can cause significant hazards and even claim life. However, with telemedicine, the decision-making process gets immense improvement as it offers real-time consultation with cardiac specialists. With the help of such telehealth solutions, emergency cardiac care specialists collaborate together remotely with other cardiac experts for better diagnosis and interventions. This further helps in improved decision-making during cardiac emergencies. 

Recommend Post: The Role of ECG Monitoring in Preventing Sudden Cardiac Arrest

Convenience

A cardiac emergency is a special condition which needs immediate care and support. In such conditions, taking the patient to the doctor or taking the doctor to the patient both are time-consuming. However, when patients leverage telehealth solutions they can access emergency cardiac care on time, remotely, according to their convince. 

Quality care

Enhanced emergency cardiac care also means quality care at the right time. When patients and cardiac specialists leverage telemedicine solutions they can access/provide real-time quality care for cardiac emergencies. With telehealth solutions, cardiac specialists diagnose and offer treatment instructions in real time using communication technologies. Therefore, they can provide quality care during cardiac emergencies remotely. 

Streamlined follow-ups

Lastly, telehealth solutions extend beyond emergency care and also include follow-ups and consultations remotely. As a result, these telehealth solutions not only enhance emergency cardiac care but also offer essential aftercare to ensure quality support remotely for post-cardiac emergency care. 

Conclusion 

Cardiac emergencies can be life-threatening and require immediate end effective treatment support to help the patient survive the condition. Advanced healthcare solutions such as telemedicine work miracles in transforming cardiac emergency care. By integrating telemedicine for cardiac care specialists, can provide enhanced cardiac support for emergencies without the need for physical consultation, diagnosis and emergency care. 

[claraisabelle]

Cardiac Monitoring Services: Comprehensive Solutions for Heart Health

Cardiac health is crucial for overall well-being, and early detection of heart-related issues can save lives. Cardiac monitoring services provide a vital tool for continuous assessment of heart activity, ensuring timely intervention and preventing severe complications. This service is especially beneficial for individuals with existing heart conditions or those at risk for cardiovascular disease. iMagnum Healthcare offers state-of-the-art cardiac monitoring services designed to keep patients and healthcare providers informed and proactive in managing heart health.

What Are Cardiac Monitoring Services?

Cardiac monitoring services involve the use of specialized devices to track a patient’s heart rhythm and electrical activity over a set period. These devices range from short-term, wearable monitors like Holter monitors, to longer-term, remote monitoring technologies such as mobile cardiac telemetry (MCT). By capturing real-time data, cardiac monitoring services help detect irregularities such as arrhythmias, which could otherwise go unnoticed.

These services are essential for:

Detecting heart rhythm irregularities (arrhythmias).

Monitoring heart activity post-surgery.

Managing patients with chronic heart conditions.

Guiding treatment plans based on real-time heart data.

Types of Cardiac Monitoring

There are several types of cardiac monitoring systems available, each serving specific diagnostic purposes:

Holter Monitor

A Holter monitor is a portable device worn by a patient to record heart activity continuously over 24-48 hours. It captures every heartbeat, providing a detailed record of heart function during normal daily activities. This helps detect patterns and abnormalities in heart rhythm that may not be noticeable during a short doctor's visit.

Event Monitor

An event monitor is designed for patients who experience sporadic symptoms, such as dizziness or heart palpitations, over a longer period. Unlike a Holter monitor, an event monitor only records when activated by the patient or when it detects abnormal activity. These monitors are typically worn for weeks or even months to capture transient symptoms that occur infrequently.

Mobile Cardiac Telemetry (MCT)

MCT is an advanced form of continuous cardiac monitoring that transmits real-time data to healthcare providers wirelessly. This system can detect and transmit data instantly when abnormal heart activity occurs, enabling immediate intervention if needed. MCT is ideal for patients who require continuous monitoring over longer periods or for those at high risk of cardiac events.

Benefits of Cardiac Monitoring Services

The advantages of cardiac monitoring services extend beyond simple heart rhythm tracking. These services offer profound insights that guide healthcare providers in developing personalized treatment plans and ensuring patient safety. Key benefits include:

Early Detection of Heart Conditions

By continuously tracking heart activity, monitoring services enable the early detection of arrhythmias and other cardiac issues. Early detection is critical in preventing heart attacks, strokes, or other severe cardiovascular complications.

Improved Patient Outcomes

Cardiac monitoring allows for the timely adjustment of treatment protocols based on real-time data, improving the overall effectiveness of care. It can also help prevent hospital readmissions by closely monitoring patients after surgeries or other cardiac procedures.

Remote Monitoring and Real-Time Data

With the advancement of mobile telemetry and remote monitoring devices, healthcare providers can receive real-time updates on a patient’s condition from anywhere. This ensures that immediate medical action can be taken when necessary, even if the patient is not in a clinical setting.

Non-Invasive and Convenient

Cardiac monitors are easy to use, non-invasive, and typically do not interfere with daily activities. Wearable devices provide comfort and ease for patients, allowing them to maintain normal routines while being monitored.

Who Needs Cardiac Monitoring Services?

Cardiac monitoring services are recommended for a wide range of patients. These include:

Individuals with known arrhythmias or irregular heartbeats.

Patients recovering from heart surgery or other cardiac procedures.

Those with a history of heart disease or stroke.

Patients with unexplained symptoms such as chest pain, dizziness, or fainting.

Individuals at risk for sudden cardiac arrest.

How Cardiac Monitoring Services Work

Cardiac monitoring devices, whether they are short-term (like Holter monitors) or long-term (such as MCT), work by recording the electrical impulses generated by the heart. These impulses are analyzed to detect any irregularities in heart rhythm. The process involves:

Device Setup: A healthcare provider fits the patient with a monitor that will record their heart’s electrical activity. This can range from a small device worn around the chest to a wrist-worn or patch-like sensor.

Data Recording: The device captures heart activity, either continuously or intermittently, depending on the type of monitor. Event monitors, for example, only record when the patient feels symptoms or when an irregular heartbeat is detected.

Data Transmission: In advanced systems like mobile telemetry, the data is transmitted in real-time to healthcare providers who analyze it and make decisions about the patient’s care.

Analysis: Healthcare professionals review the data, looking for abnormalities such as arrhythmias or other cardiac events. Based on this data, they can make adjustments to treatment plans or recommend further action.

Technological Advancements in Cardiac Monitoring

The field of cardiac monitoring has seen rapid advancements, with new technologies making monitoring more accurate, accessible, and comfortable for patients.

Wearable Devices

Wearable cardiac monitors, such as smartwatches and chest patches, have revolutionized the ease with which patients can be monitored. These devices not only track heart rhythm but also offer other health-related data such as oxygen levels and physical activity.

Artificial Intelligence (AI) Integration

AI-powered cardiac monitoring systems are now capable of predicting potential cardiac events by analyzing large volumes of real-time data. This predictive analysis can alert both patients and healthcare providers before a significant event occurs, offering an unprecedented level of preventative care.

Choosing the Right Cardiac Monitoring Service

When choosing a cardiac monitoring service, patients and physicians should consider several factors, including the duration of monitoring required, the reliability of the device, and the quality of customer support. Providers like iMagnum Healthcare offer customized cardiac monitoring solutions tailored to the specific needs of each patient, ensuring high-quality care and accurate results.

Why Choose iMagnum Healthcare for Cardiac Monitoring Services?

iMagnum Healthcare is a trusted provider of advanced cardiac monitoring services. With cutting-edge technology and a team of expert healthcare professionals, they offer:

Customized Solutions: Tailored monitoring options based on the patient’s condition and requirements.

24/7 Support: Continuous monitoring backed by around-the-clock support, ensuring immediate attention to any irregularities.

Advanced Technology: The latest in mobile cardiac telemetry, Holter monitors, and AI-driven solutions.

By providing high-quality, patient-focused cardiac monitoring services, iMagnum Healthcare helps individuals manage their heart health effectively and with confidence.

Frequently Asked Questions (FAQs)

What is cardiac monitoring and why is it important? Cardiac monitoring tracks your heart’s electrical activity to detect any abnormalities. It is crucial for early detection of heart problems, which can prevent severe complications.

How does a Holter monitor differ from other cardiac monitors? A Holter monitor records your heart activity continuously for 24-48 hours, while other monitors, like event monitors, record intermittently when triggered by symptoms.

How long will I need to wear a cardiac monitor? The duration depends on your condition and the type of monitor. It can range from 24 hours for a Holter monitor to several weeks for an event monitor.

Is cardiac monitoring safe for long-term use? Yes, cardiac monitoring devices are non-invasive and safe for both short-term and long-term use.

Can cardiac monitoring detect all heart problems? Cardiac monitoring can detect a wide range of heart conditions, particularly arrhythmias, but it may not detect all structural heart problems.

Will my insurance cover cardiac monitoring services? Most insurance plans cover cardiac monitoring services, but it is best to confirm with your provider.

Conclusion

Cardiac monitoring services are an essential tool in modern healthcare, offering continuous insights into heart health and enabling early intervention in case of irregularities. With advanced technology and expert support, iMagnum Healthcare provides reliable and customized solutions to help patients manage their heart conditions and live healthier lives.

[neuphony9]

The EXG Synapse by Neuphony is an advanced device designed to monitor and analyze multiple biosignals, including EEG, ECG, and EMG. It offers real-time data for research and neurofeedback, making it ideal for cognitive enhancement and physiological monitoring.

[gadgetgeniusinsights]

Fitbit Charge 5

Check out our latest review of the Fitbit Charge 5! Discover its top features and how it can enhance your fitness journey. 🏃‍♂��💪 #FitbitCharge5 #FitnessTracker #HealthTech

Visit the Fitbit Store Operating System: Android, IosSpecial Feature: GPSConnectivity Technology: GPSGPS: TrueShape: HeartScreen Size: 50 MillimetersBrand: FitbitModel Name: Charge 5, paceStyle: ModernColor: Graphite Stainless Steel $129.94 BUY About this item EXCLUSIVE BUNDLE INCLUDES: 1x Fitbit Charge 5, 1x Charging Cable, 1x Infinity Band (Small & Large), 1x Compatible Wall Charging…

[road-tosuccess]

Top Health and Wellness Products | Amazon Picks

Welcome to our guide on the best health and wellness products available on Amazon!

Whether you are starting your journey towards a healthier lifestyle or looking to upgrade your current wellness routine, this blog post will introduce you to some top-notch products that can support your goals.

From essential supplements to state-of-the-art fitness trackers, we’ve got you covered.

[swooshdental]

Best Dental Hopsital in Nallagandla-SwooshDental

Address:

1st floor, Sirvi Landmark, Beside Canara Bank, Near Indian Oil Petrol Pump Kanchi Gachibowli Road Nallagandla, Serilingampally, Hyderabad, Telangana 500019

Phone No: 086057 78596

[hazmoonstore]

haz moon هاز مون هزمون Unboxing and Review of the Haz moon T800 Ultra Smart Watch | The Perfect Companion for a Connected Lifestyle

https://hazmoon.store/?route=product/product&product_id=122

تكنولوجيا وتصميم متطور: اختبر الجمع المثالي بين التكنولوجيا المتطورة والتصميم الأنيق مع ساعة Haz moon T800 الذكية الفائقة. تم تصميم هذه الساعة الذكية بدقة واهتمام بالتفاصيل، وهي تعكس الابتكار والأناقة. يعمل الجهاز بشريحة استهلاك الطاقة منخفضة الاستهلاك لتوفير عمر بط��رية طويل دون التأثير على الأداء. قل وداعًا للشحن المتكرر واستمتع بالاستخدام المستمر طوال اليوم. يوفر العرض الكبير على شاشة LCD رؤية واضحة وحية، مما يضمن رؤية مثلى حتى في ضوء الشمس المشرق. احصل على تجربة بصرية مميزة على معصمك.

هل تستحق ساعة هاز مون تي ٨٠٠ الترا سمارت واتش  الضجة المحيطة بها؟ اكتشف الآن!

Cutting-Edge Technology and Design for an Enhanced User Experience

Cutting-Edge Technology and Design: Experience the perfect blend of cutting-edge technology and sleek design with the Haz moon Store T800 Ultra Smart Watch. Crafted with precision and attention to detail, this smartwatch is a testament to innovation and style. Powered by an ultra-low power consumption chip, the T800 Ultra ensures long-lasting battery life without compromising on performance. Say goodbye to frequent charging and enjoy uninterrupted usage throughout the day. The large LCD display provides clear and vibrant visuals, ensuring optimal visibility even in bright sunlight. Experience a visual feast on your wrist.

T800 Ultra Smart Watch

Smartwatch with health monitoring

Blood pressure monitoring wearable device

Connected lifestyle smartwatch

Hands-free communication smartwatch

Customizable dial smartwatch

Long-lasting battery smartwatch

Fitness tracking smartwatch

Cutting-edge technology smartwatch

Sleek design smartwatch

https://youtu.be/U24kg3h40v4

[crazydiscostu]

RingConn Smart Ring

The emerging and vast universe of wearable technology continues to expand as the human race integrates it seamlessly into their day to day activities. From smartwatches to fitness trackers, these gadgets have become integral companions on our journey towards better health and wellness. Today we’re looking at one of those latest innovations – the RingConn Smart Ring, a sleek and sophisticated…

[pritchardautobody]

Your Trusted Destination for Transmission Services in Winnipeg

[jcmarchi]

Detachable cardiac pacing lead may improve safety for cardiac patients

New Post has been published on https://thedigitalinsider.com/detachable-cardiac-pacing-lead-may-improve-safety-for-cardiac-patients/

Detachable cardiac pacing lead may improve safety for cardiac patients

In 2012, Neil Armstrong, the first man to walk on the moon, died of post-surgery complications at the age of 82 following what should have been a routine heart surgery. Armstrong had undergone bypass surgery, the most common open-heart operation in the United States, and a surgery where the overall chance of death has dropped to almost zero.

Armstrong’s death was caused by heart damage that occurred during the removal of temporary cardiac pacing leads. Pacing leads are routinely used to monitor patients and protect against the risk of postoperative arrhythmias, including complete blockages, during the recovery period after cardiac surgery. However, because current methods rely on surgical suturing or direct insertion of electrodes to the heart tissue, trauma can occur during implantation and removal, increasing the potential for damage, bleeding, and device failure.

A coffee chat in 2019 about Armstrong’s untimely death helped inspire new research, published in the journal Science Translational Medicine. The research demonstrates findings that may offer a promising new platform for adhesive bioelectronic devices for cardiac monitoring, diagnosis, and treatment, and offer inspiration for the future development of bioadhesive electronics.

“While discussing the story, our team had a eureka moment that we probably could do something to prevent such complications by realizing a completely atraumatic version of it based on our bioadhesive technologies,” says Hyunwoo Yuk SM ’16, PhD ’21, a former MIT research scientist who is now the chief technology officer at SanaHeal. “It was such an exciting idea, and the rest was just making it happen.”

The team, comprising researchers affiliated with the lab of Xuanhe Zhao, professor of mechanical engineering and of civil and environmental engineering, has introduced a 3D-printable bioadhesive pacing lead that can directly interface with cardiac tissue, supporting minimally invasive adhesive implantation and providing a detachment solution that allows for gentle removal. Yuk and Zhao are the corresponding authors of the study; former MIT researcher Jue Deng is the paper’s first author.

“This work introduces the first on-demand detachable bioadhesive version of temporary cardiac pacing lead that offers atraumatic application and removal of the device with enhanced safety while offering improved bioelectronic performance,” says Zhao.

The development of the bioadhesive pacing lead is a combination of technologies that the team has developed over the last several years in the field of bioadhesive, bioelectronics, and 3D printing. SanaHeal, a company born from the team’s ongoing work, is commercializing bioadhesive technologies for various clinical applications.

“We hope that our ongoing effort on commercialization of our bioadhesive technology might help faster clinical translation of our bioadhesive pacing lead as well,” says Yuk.

[techdriveplay]

How Technology is Changing the Way We Workout

Over the last 10 years, the fitness industry has seen an explosion in the use and adoption of technology, from the rise of wearable fitness devices to the integration of A.I. at your local gym. There looks to be no slowing down the tsunami of tech innovation within the fitness space. The Impact of Wearable Technology According to a study published in the Journal of Medical Internet Research,…

[sevenoakstransmissions]

[market-insider]

Extracorporeal Membrane Oxygenation Machine | Exploring Opportunities and Challenges

The global extracorporeal membrane oxygenation machine market size is anticipated to reach to reach USD 445.7 million by 2030, expanding at a CAGR of 5.5% from 2024 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the rising prevalence of cardiopulmonary and respiratory diseases, increasing adoption of ECMO machines in hospitals, and technological advancements in ECMO machines. The market expansion is also driven by the need for advanced life support technologies like ECMO machines, which are becoming increasingly necessary in treating patients with severe or life-threatening cardiac or pulmonary conditions.

Extracorporeal Membrane Oxygenation Machine Market Report Highlights

In 2023, the oxygenators segment accounted for the largest market share. This can be attributed due to prevalence of diseases like coronary heart disease and chronic obstructive pulmonary disease (COPD) continues to rise, the demand for advanced life support technologies like ECMO machines increases, driving the growth of the oxygenators segment.

The veno-arterial segment dominated the modality segment of ECMO machine market in 2023. This growth can be attributed due to high usage of veno-arterial ECMO in treating patients with cardiac arrest, where it assists with algorithm life support strategies to restore blood circulation. Additionally, the increasing incidence of chronic obstructive pulmonary disease (COPD) is also a key driver of this market segment.

The respiratory segment dominated the application segment in 2023 due to the high prevalence of respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and acute respiratory distress syndrome (ARDS), which are leading causes of death worldwide, necessitate advanced life support technologies like ECMO machines.

The adult patient segment dominated the patient type segment in 2023 due to the prevalent incidence of heart and lung-related issues necessitating life-saving interventions.

The North American region held the largest share of the market in 2023 due to key industry players, consistent product launches, government backing for quality healthcare, advanced healthcare infrastructure, and favorable reimbursement policies.

Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas.

For More Details or Sample Copy please visit link @: Extracorporeal Membrane Oxygenation Machine Market Report

The rising prevalence of cardiovascular and respiratory diseases. Diseases such as coronary heart disease, cerebrovascular disease, rheumatic and congenital heart diseases, respiratory diseases like acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary diseases are leading causes of death worldwide. For instance, according to the World Heart Federation, approximately 18.6 million people die annually from cardiovascular diseases. Additionally, about 190,000 Americans are diagnosed with ARDS annually in the U.S. Such an increasing prevalence of cardiovascular and respiratory diseases has boosted the demand for ECMO machines, driving the market growth.

In addition, the increasing rate of technical improvement is increasing the usage of products. It is easier to transfer critically ill patients now as machine parts like hollow pumps and oxygenators are smaller. Moreover, introducing technologically advanced components, such as improved rotary pumps, dual-lumen cannulas, innovative oxygenators, and new cannulation approaches, is anticipated to ease the use of ECMO machines. For instance, in 2022, Inspira Technologies OXY B.H.N. Ltd. recently introduced the "Liby" System, an advanced life support system used to treat patients with life-threatening heart and lung failure. Similar advancements and the introduction of new products are expected to drive market growth in the coming years.